Accuray reports Q3 EPS (6c), consensus (1c)

Reports Q3 revenue $101.1M, consensus $113.65M. “While I am disappointed in our quarterly results where we faced challenges as a result of multiple factors, including a delay in product shipments and slower than expected U.S. installations, we remain confident in our growth strategy and our ability to offer value to our customers globally,” said Suzanne Winter, CEO. “FY24 is an important year for the company as we start to make major advances in long-term growth and profitability drivers, which we highlighted at our investor day this past fall. We remain focused on executing on our plan to advance care with innovative solutions, improving patient access by penetrating higher growth emerging markets and investing in our service business. Finally, I am very pleased with customer adoption of our solutions this quarter that led to a 21% increase in gross orders year-over-year, fueling future revenue and EBITDA growth.”